💊 90% of drugs fail. Clinical trials take years. And billions are lost every time.In this episode of Founders & Builders, I sit down with Dr. Olga Kubassova, a mathematician turned biotech investor, and founder of Image Analysis Group — a company using AI-powered imaging biomarkers to reinvent how we measure whether a drug is actually working.We cover:🧠 Why clinical trials are broken — and what needs to change📉 How AI biomarkers let us see disease earlier and treatment faster⚙️ What makes a billion-dollar drug fail — and how we can spot it sooner💡 Olga’s journey from math PhD to advising governments and top pharma🏥 The future of precision medicine and data-driven trialsOne of my favorite moments:“If you can see disease earlier and measure treatment faster — that’s the difference between a failed drug and a billion-dollar success.”This is a conversation about the future of medicine — and how AI is changing everything.

Ver todos los episodios